questionsmedicales.fr
Maladies métaboliques et nutritionnelles
Maladies métaboliques
Erreurs innées du métabolisme
Erreurs innées du métabolisme lipidique
Erreurs innées du métabolisme lipidique : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Erreurs innées du métabolisme lipidique : Questions médicales les plus fréquentes",
"headline": "Erreurs innées du métabolisme lipidique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Erreurs innées du métabolisme lipidique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-12",
"dateModified": "2025-05-07",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Erreurs innées du métabolisme lipidique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Erreurs innées du métabolisme",
"url": "https://questionsmedicales.fr/mesh/D008661",
"about": {
"@type": "MedicalCondition",
"name": "Erreurs innées du métabolisme",
"code": {
"@type": "MedicalCode",
"code": "D008661",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Syndrome de Barth",
"alternateName": "Barth Syndrome",
"url": "https://questionsmedicales.fr/mesh/D056889",
"about": {
"@type": "MedicalCondition",
"name": "Syndrome de Barth",
"code": {
"@type": "MedicalCode",
"code": "D056889",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.398.224"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hyperlipidémie familiale mixte",
"alternateName": "Hyperlipidemia, Familial Combined",
"url": "https://questionsmedicales.fr/mesh/D006950",
"about": {
"@type": "MedicalCondition",
"name": "Hyperlipidémie familiale mixte",
"code": {
"@type": "MedicalCode",
"code": "D006950",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.398.450"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hyperlipoprotéinémie de type I",
"alternateName": "Hyperlipoproteinemia Type I",
"url": "https://questionsmedicales.fr/mesh/D008072",
"about": {
"@type": "MedicalCondition",
"name": "Hyperlipoprotéinémie de type I",
"code": {
"@type": "MedicalCode",
"code": "D008072",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.398.465"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hyperlipoprotéinémie de type II",
"alternateName": "Hyperlipoproteinemia Type II",
"url": "https://questionsmedicales.fr/mesh/D006938",
"about": {
"@type": "MedicalCondition",
"name": "Hyperlipoprotéinémie de type II",
"code": {
"@type": "MedicalCode",
"code": "D006938",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.398.481"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hypercholestérolémie familiale homozygote",
"alternateName": "Homozygous Familial Hypercholesterolemia",
"url": "https://questionsmedicales.fr/mesh/D000090542",
"about": {
"@type": "MedicalCondition",
"name": "Hypercholestérolémie familiale homozygote",
"code": {
"@type": "MedicalCode",
"code": "D000090542",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.398.481.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Hyperlipoprotéinémie de type III",
"alternateName": "Hyperlipoproteinemia Type III",
"url": "https://questionsmedicales.fr/mesh/D006952",
"about": {
"@type": "MedicalCondition",
"name": "Hyperlipoprotéinémie de type III",
"code": {
"@type": "MedicalCode",
"code": "D006952",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.398.483"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hyperlipoprotéinémie de type IV",
"alternateName": "Hyperlipoproteinemia Type IV",
"url": "https://questionsmedicales.fr/mesh/D006953",
"about": {
"@type": "MedicalCondition",
"name": "Hyperlipoprotéinémie de type IV",
"code": {
"@type": "MedicalCode",
"code": "D006953",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.398.487"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hyperlipoprotéinémie de type V",
"alternateName": "Hyperlipoproteinemia Type V",
"url": "https://questionsmedicales.fr/mesh/D006954",
"about": {
"@type": "MedicalCondition",
"name": "Hyperlipoprotéinémie de type V",
"code": {
"@type": "MedicalCode",
"code": "D006954",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.398.493"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hypolipoprotéinémies",
"alternateName": "Hypolipoproteinemias",
"url": "https://questionsmedicales.fr/mesh/D007009",
"about": {
"@type": "MedicalCondition",
"name": "Hypolipoprotéinémies",
"code": {
"@type": "MedicalCode",
"code": "D007009",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.398.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hypoalphalipoprotéinémies",
"alternateName": "Hypoalphalipoproteinemias",
"url": "https://questionsmedicales.fr/mesh/D052456",
"about": {
"@type": "MedicalCondition",
"name": "Hypoalphalipoprotéinémies",
"code": {
"@type": "MedicalCode",
"code": "D052456",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.398.500.330"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Déficit en lécithine-cholestérol-acyl-transférase",
"alternateName": "Lecithin Cholesterol Acyltransferase Deficiency",
"url": "https://questionsmedicales.fr/mesh/D007863",
"about": {
"@type": "MedicalCondition",
"name": "Déficit en lécithine-cholestérol-acyl-transférase",
"code": {
"@type": "MedicalCode",
"code": "D007863",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.398.500.330.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Maladie de Tangier",
"alternateName": "Tangier Disease",
"url": "https://questionsmedicales.fr/mesh/D013631",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Tangier",
"code": {
"@type": "MedicalCode",
"code": "D013631",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.398.500.330.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Déficit en lécithine-cholestérol-acyl-transférase",
"alternateName": "Lecithin Cholesterol Acyltransferase Deficiency",
"url": "https://questionsmedicales.fr/mesh/D007863",
"about": {
"@type": "MedicalCondition",
"name": "Déficit en lécithine-cholestérol-acyl-transférase",
"code": {
"@type": "MedicalCode",
"code": "D007863",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.398.500.330.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Maladie de Tangier",
"alternateName": "Tangier Disease",
"url": "https://questionsmedicales.fr/mesh/D013631",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Tangier",
"code": {
"@type": "MedicalCode",
"code": "D013631",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.398.500.330.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hypobêtalipoprotéinémies",
"alternateName": "Hypobetalipoproteinemias",
"url": "https://questionsmedicales.fr/mesh/D006995",
"about": {
"@type": "MedicalCondition",
"name": "Hypobêtalipoprotéinémies",
"code": {
"@type": "MedicalCode",
"code": "D006995",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.398.500.440"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Abêtalipoprotéinémie",
"alternateName": "Abetalipoproteinemia",
"url": "https://questionsmedicales.fr/mesh/D000012",
"about": {
"@type": "MedicalCondition",
"name": "Abêtalipoprotéinémie",
"code": {
"@type": "MedicalCode",
"code": "D000012",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.398.500.440.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Abêtalipoprotéinémie",
"alternateName": "Abetalipoproteinemia",
"url": "https://questionsmedicales.fr/mesh/D000012",
"about": {
"@type": "MedicalCondition",
"name": "Abêtalipoprotéinémie",
"code": {
"@type": "MedicalCode",
"code": "D000012",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.398.500.440.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Lipidoses",
"alternateName": "Lipidoses",
"url": "https://questionsmedicales.fr/mesh/D008064",
"about": {
"@type": "MedicalCondition",
"name": "Lipidoses",
"code": {
"@type": "MedicalCode",
"code": "D008064",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.398.641"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Céroïdes-lipofuscinoses neuronales",
"alternateName": "Neuronal Ceroid-Lipofuscinoses",
"url": "https://questionsmedicales.fr/mesh/D009472",
"about": {
"@type": "MedicalCondition",
"name": "Céroïdes-lipofuscinoses neuronales",
"code": {
"@type": "MedicalCode",
"code": "D009472",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.398.641.509"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Syndrome de Sjögren-Larsson",
"alternateName": "Sjogren-Larsson Syndrome",
"url": "https://questionsmedicales.fr/mesh/D016111",
"about": {
"@type": "MedicalCondition",
"name": "Syndrome de Sjögren-Larsson",
"code": {
"@type": "MedicalCode",
"code": "D016111",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.398.641.723"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Xanthomatose cérébrotendineuse",
"alternateName": "Xanthomatosis, Cerebrotendinous",
"url": "https://questionsmedicales.fr/mesh/D019294",
"about": {
"@type": "MedicalCondition",
"name": "Xanthomatose cérébrotendineuse",
"code": {
"@type": "MedicalCode",
"code": "D019294",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.398.925"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Erreurs innées du métabolisme lipidique",
"alternateName": "Lipid Metabolism, Inborn Errors",
"code": {
"@type": "MedicalCode",
"code": "D008052",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Carlos R Ferreira",
"url": "https://questionsmedicales.fr/author/Carlos%20R%20Ferreira",
"affiliation": {
"@type": "Organization",
"name": "Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States; Rare Disease Institute, Children's National Health System, Washington, DC, United States."
}
},
{
"@type": "Person",
"name": "Clara D M van Karnebeek",
"url": "https://questionsmedicales.fr/author/Clara%20D%20M%20van%20Karnebeek",
"affiliation": {
"@type": "Organization",
"name": "Departments of Pediatrics and Clinical Genetics, Amsterdam University Medical Centers, Amsterdam, The Netherlands; Department of Pediatrics, Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, BC, Canada. Electronic address: c.d.vankarnebeek@amstedarmumc.nl."
}
},
{
"@type": "Person",
"name": "Jerry Vockley",
"url": "https://questionsmedicales.fr/author/Jerry%20Vockley",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatrics, University of Pittsburgh School of Medicine, Department of Human Genetics, Graduate School of Public Health, Pittsburgh, Pennsylvania, USA."
}
},
{
"@type": "Person",
"name": "Andrea L Gropman",
"url": "https://questionsmedicales.fr/author/Andrea%20L%20Gropman",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, Children's National, Washington, DC 20010, USA."
}
},
{
"@type": "Person",
"name": "Sumreena Mansoor",
"url": "https://questionsmedicales.fr/author/Sumreena%20Mansoor",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry, Shifa College of Medicine, Shifa Tameer-e-millat university, H-8/4, Islamabad, Pakistan. dr.sumreena@gmail.com."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Patient satisfaction - results of cluster analysis of finnish patients.",
"datePublished": "2023-06-13",
"url": "https://questionsmedicales.fr/article/37312180",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12913-023-09625-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "RNAprofiling 2.0: Enhanced Cluster Analysis of Structural Ensembles.",
"datePublished": "2023-03-17",
"url": "https://questionsmedicales.fr/article/36933824",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jmb.2023.168047"
}
},
{
"@type": "ScholarlyArticle",
"name": "Analysis of the Intelligent Tourism Route Planning Scheme Based on the Cluster Analysis Algorithm.",
"datePublished": "2022-06-28",
"url": "https://questionsmedicales.fr/article/35800698",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2022/3310676"
}
},
{
"@type": "ScholarlyArticle",
"name": "Analysis of Graphic Perception Education for Young Children Based on Fuzzy Clustering Analysis.",
"datePublished": "2022-06-21",
"url": "https://questionsmedicales.fr/article/35774433",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2022/8046713"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comparative Analysis of the Performance of Complex Texture Clustering Driven by Computational Intelligence Methods Using Multiple Clustering Models.",
"datePublished": "2022-09-29",
"url": "https://questionsmedicales.fr/article/36210982",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2022/8449491"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies métaboliques et nutritionnelles",
"item": "https://questionsmedicales.fr/mesh/D009750"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies métaboliques",
"item": "https://questionsmedicales.fr/mesh/D008659"
},
{
"@type": "ListItem",
"position": 4,
"name": "Erreurs innées du métabolisme",
"item": "https://questionsmedicales.fr/mesh/D008661"
},
{
"@type": "ListItem",
"position": 5,
"name": "Erreurs innées du métabolisme lipidique",
"item": "https://questionsmedicales.fr/mesh/D008052"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Erreurs innées du métabolisme lipidique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Erreurs innées du métabolisme lipidique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Erreurs innées du métabolisme lipidique",
"description": "Comment diagnostique-t-on une erreur métabolique lipidique ?\nQuels tests sont utilisés pour le diagnostic ?\nLes symptômes aident-ils au diagnostic ?\nQuelle est l'importance de l'histoire familiale ?\nPeut-on utiliser l'imagerie pour le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D008052?mesh_terms=Cluster+Analysis&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Erreurs innées du métabolisme lipidique",
"description": "Quels sont les symptômes courants ?\nLes symptômes varient-ils selon le type d'erreur ?\nY a-t-il des signes cutanés associés ?\nLes symptômes apparaissent-ils à la naissance ?\nLes troubles mentaux sont-ils possibles ?",
"url": "https://questionsmedicales.fr/mesh/D008052?mesh_terms=Cluster+Analysis&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Erreurs innées du métabolisme lipidique",
"description": "Peut-on prévenir ces erreurs ?\nLe conseil génétique est-il utile ?\nLes vaccinations sont-elles importantes ?\nLes tests prénataux sont-ils recommandés ?\nL'éducation des parents est-elle cruciale ?",
"url": "https://questionsmedicales.fr/mesh/D008052?mesh_terms=Cluster+Analysis&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Erreurs innées du métabolisme lipidique",
"description": "Quels traitements sont disponibles ?\nLa diététique joue-t-elle un rôle ?\nDes médicaments sont-ils utilisés ?\nLa thérapie génique est-elle une option ?\nLes greffes d'organes sont-elles nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D008052?mesh_terms=Cluster+Analysis&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Erreurs innées du métabolisme lipidique",
"description": "Quelles complications peuvent survenir ?\nLes erreurs lipidique peuvent-elles être mortelles ?\nY a-t-il des risques de cancer ?\nLes troubles psychologiques sont-ils fréquents ?\nLes complications sont-elles réversibles ?",
"url": "https://questionsmedicales.fr/mesh/D008052?mesh_terms=Cluster+Analysis&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Erreurs innées du métabolisme lipidique",
"description": "Quels sont les facteurs de risque génétiques ?\nL'origine ethnique influence-t-elle le risque ?\nL'alimentation joue-t-elle un rôle ?\nLes infections peuvent-elles aggraver la condition ?\nLe sexe influence-t-il le risque ?",
"url": "https://questionsmedicales.fr/mesh/D008052?mesh_terms=Cluster+Analysis&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on une erreur métabolique lipidique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sanguins, des analyses génétiques et des biopsies."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de dépistage néonatal, des dosages enzymatiques et des analyses d'urine sont courants."
}
},
{
"@type": "Question",
"name": "Les symptômes aident-ils au diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes cliniques orientent le diagnostic et peuvent indiquer le type d'erreur."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'histoire familiale ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'histoire familiale aide à identifier les risques génétiques et à orienter les tests."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser l'imagerie pour le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie peut aider à évaluer les organes affectés, mais n'est pas spécifique."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, douleurs abdominales, troubles neurologiques et retard de croissance."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type d'erreur ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque type d'erreur lipidique présente des symptômes spécifiques et variés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes cutanés associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines erreurs peuvent provoquer des dépôts lipidiques visibles sur la peau."
}
},
{
"@type": "Question",
"name": "Les symptômes apparaissent-ils à la naissance ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains symptômes peuvent apparaître dès la naissance, d'autres se développent plus tard."
}
},
{
"@type": "Question",
"name": "Les troubles mentaux sont-ils possibles ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles cognitifs et comportementaux peuvent survenir dans certaines erreurs."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir ces erreurs ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention est limitée, mais le dépistage néonatal peut aider à identifier les cas précoces."
}
},
{
"@type": "Question",
"name": "Le conseil génétique est-il utile ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le conseil génétique aide les familles à comprendre les risques et les options de dépistage."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles importantes ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccinations ne préviennent pas les erreurs métaboliques, mais protègent contre d'autres maladies."
}
},
{
"@type": "Question",
"name": "Les tests prénataux sont-ils recommandés ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests prénataux peuvent être proposés pour détecter certaines erreurs génétiques."
}
},
{
"@type": "Question",
"name": "L'éducation des parents est-elle cruciale ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, informer les parents sur les signes et symptômes peut aider à une détection précoce."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des régimes alimentaires spécifiques, des suppléments et des médicaments."
}
},
{
"@type": "Question",
"name": "La diététique joue-t-elle un rôle ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un régime adapté est crucial pour gérer les niveaux de lipides et prévenir les complications."
}
},
{
"@type": "Question",
"name": "Des médicaments sont-ils utilisés ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments peuvent être prescrits pour réduire les niveaux de lipides ou traiter les symptômes."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle une option ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est en recherche pour certaines erreurs, mais n'est pas encore courante."
}
},
{
"@type": "Question",
"name": "Les greffes d'organes sont-elles nécessaires ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans certains cas graves, des greffes peuvent être envisagées pour traiter des dommages organiques."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des maladies hépatiques, des troubles neurologiques et des problèmes cardiaques."
}
},
{
"@type": "Question",
"name": "Les erreurs lipidique peuvent-elles être mortelles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines erreurs peuvent entraîner des complications graves pouvant être fatales sans traitement."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de cancer ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines erreurs peuvent augmenter le risque de développer certains types de cancer."
}
},
{
"@type": "Question",
"name": "Les troubles psychologiques sont-ils fréquents ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles psychologiques peuvent survenir en raison de l'impact des symptômes."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes sans traitement."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque génétiques ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux d'erreurs métaboliques augmentent le risque de transmission."
}
},
{
"@type": "Question",
"name": "L'origine ethnique influence-t-elle le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines erreurs sont plus fréquentes dans des populations spécifiques en raison de la génétique."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation déséquilibrée peut exacerber les symptômes chez les individus prédisposés."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles aggraver la condition ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections peuvent déclencher ou aggraver les symptômes des erreurs métaboliques."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines erreurs métaboliques peuvent avoir une prévalence différente selon le sexe."
}
}
]
}
]
}
Healthcare providers must understand patients' expectations and perceptions of the care they receive to provide high-quality care. The purpose of this study is to identify and analyse different cluste...
A cross-sectional design was applied. The data were collected in 2017 from three Finnish acute care hospitals with the Revised Humane Caring Scale (RHCS) as a paper questionnaire, including six backgr...
A total of 1810 patients participated in the study. Patient satisfaction was categorised into four groups: dissatisfied (n = 58), moderately dissatisfied (n = 249), moderately satisfied (n = 608), and...
The results mostly demonstrated high levels of patient satisfaction; however, the perceptions of minority populations of dissatisfied patients should be assessed to identify shortcomings in the care p...
Understanding the base pairing of an RNA sequence provides insight into its molecular structure. By mining suboptimal sampling data, RNAprofiling 1.0 identifies the dominant helices in low-energy seco...
In view of the problems of the traditional cluster analysis algorithm such as strong dependence on the initial cluster center, the traditional...
Geometric ability includes elements of identification, conceptualization, combination, drawing, and reasoning, and graphic perception is an important part of it. Kindergarten science education include...
Traditional texture cluster algorithms are frequently used in engineering; however, despite their widespread application, these algorithms continue to suffer from drawbacks including excessive complex...
Cancer has become a major health concern due to the increasing morbidity and mortality rates, and its negative social, economic consequences and the heavy financial burden incurred by cancer patients....
We conducted a cross-sectional survey of adult patients at Mohamed Sekkat and Sidi Othmane Hospitals in Casablanca, Morocco. Data collection was conducted by two trained interviewers who administered ...
The cluster-based analysis showed that participants in cluster 1 had the highest mean attitude score (13.9 ± 2.15) and percentage of individuals with a high level of knowledge (50.8%) whereas the lowe...
The findings showed that female individuals living in rural settings, belonging to an older age group, who were least likely to use health professionals as an information source had the lowest levels ...
Seizure clustering, is the most frequently reported adverse event in epilepsy monitoring unit (EMU) safety studies which, can also potentiate other adverse events, such as falls, status epilepticus, a...
A retrospective review of patients admitted to the EMU over a two-year period was completed. Data collected included patient demographics, types of epilepsy, seizure frequency, anti-seizure medication...
Two hundred seven patients were included in our study; of these, ninety patients experienced two or more seizures in a 24-hour period (24SC), and 68 patients experienced two or more seizures in a 4-ho...
Our data showed that long-acting ASMs can be protective against seizure clustering. Furthermore, patients with temporal lobe epilepsy, and those on increased numbers of ASMs, were more likely to exper...
Over the last decade, advances in understanding the pathophysiology, clinical presentation, systemic consequences and treatment responses in obstructive sleep apnea (OSA) have made individualised OSA ...
Patients diagnosed with OSA on level 1 polysomnography (PSG) were included. Clinical and co-morbidity profile, anthropometry and sleepiness scores were compiled. On PSG, apnea-hypopnea index, position...
One hundred patients (66 males) with a mean age of 49.5 ± 13.3 years were included. Snoring was reported by 94% subjects, and 50% were excessively sleepy. Two-thirds of subjects had co-morbidities, th...
This study revealed three OSA clusters with distinct demographic, anthropometric and PSG features. Further research with bigger sample size and additional parameters may pave the way for characterisin...
Previous studies suggested that distinct phenotypes of eosinophilic granulomatosis with polyangiitis (EGPA; formerly known as Churg-Strauss syndrome) could be determined by the presence or absence of ...
This study used standardized data of 15 European centers for patients with EGPA fulfilling widely accepted classification criteria. We used multiple correspondence analysis, hierarchical cluster analy...
The analyses included 489 patients diagnosed between 1984 and 2015. ANCA were detected in 37.2% of patients, mostly perinuclear ANCA (85.4%) and/or antimyeloperoxidase (87%). Compared with ANCA-negati...
Although reinforcing the known association of ANCA status with clinical manifestations, cluster analysis does not support a complete separation of EGPA in ANCA-positive and -negative subsets. Collecti...
In the present study, we applied cluster analysis (CA) in SLE patients with joint involvement to identify which disease subset most commonly develops erosive damage....
We collected clinical and laboratory data of SLE patients with a clinical history of joint involvement (arthritis/arthralgia). Ultrasonographic assessment was performed at level of MCPs and PIPs joint...
CA included 112 SLE patients (M/F 6/106; median age 45 years, IQR 17; median disease duration 96 months, IQR 165). Arthritis was observed in 82 patients (73.2%) and inflammatory arthralgia in 30 (26.8...
The application of CA made it possible to better characterise SLE phenotype including erosive arthritis. In particular, feature-driven CA leads to the identification of a more aggressive disease, due ...